DRIVE is looking for new startups – application deadline August 26

In the incubator DRIVE, you can build your Life Science startup in a unique environment. Now they are looking for new startups and the deadline for applications is August 26.

DRIVE is KI Innovation’s business incubator with a focus on life science and health. As a member of the incubator, companies gain access to KI Innovation’s broad network within the life science industry, healthcare, investors and experts with various expertise. DRIVE welcomes both life science startup companies born from ideas validated in KI Innovation’s START program, but the incubator is also open to other newly started KI or non-KI related research-based companies in life science and digital health.

Membership is free of charge, DRIVE is financed by Karolinska Institutet and partners as well as Vinnova´s Excellence programme.

Read more at KI Innovations
Read more about the application process

Published On: 13 September 2022
  • HPV Vaccination for Those Born Between 1994 and 1999

    You can now also get vaccinated at the Gynecological Clinic at Huddinge Hospital on Campus Flemingsberg. Together, we will eradicate cervical cancer!

  • Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science

    Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund (ERDF) and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.

  • BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development

    As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.

  • Sally Sow and Turn UP: Winners of the Flemingsberg Science Award IDEA 2024

    The music world can be a challenging place, both for organizers trying to reach their audience and for music lovers searching for events that suit their taste. Sally Sow, the winner of the Flemingsberg Science Award IDEA 2024, has developed Turn Up, a platform that simplifies organizing, discovering, and participating in local music events. With a focus on inclusion and accessibility, she aims to create a music scene where everyone feels welcome.

  • KTH’s Technical Preparatory Year Moves to Flemingsberg – Student Numbers Expected to Double in Autumn 2025

    In the autumn of 2025, KTH will relocate its Technical Preparatory Year spots from Södertälje to Flemingsberg, resulting in a significant increase in student numbers at Campus Flemingsberg. By nearly doubling available seats and introducing a new learning center model in collaboration with 3 municipalities, KTH aims to meet the growing demand for technical education in the region.